News & Events
Resource Library
Careers
- Life at PharmaLex
- Current Opportunities
Training

Top Bar

MENUMENU

About UsAbout Us
Our Services
- Discovery / Non-clinical
  - - - Go to Discovery / Non-clinical section >>
  - - - Strategy and Consulting
        Integrated Product Development
        Market Access
        Scientific Advice
        Statistical Services
        Toxicology Services
- Clinical Development
  - - - Go to Clinical Development section >>
  - - - Strategy and Consulting
        Clinical Program Development
        Scientific Advice
        Statistical Services
      - Regulatory Affairs
        Clinical Trial Applications
        Global Procedure Management
        Health Authority / Agency Interaction
        Regulatory Operations
    - - Pharmacovigilance
        Clinical Trial Safety Support
        Pharmacovigilance Consulting
      - Quality
        GxP Services
        Interim / Contract QA
        Quality Management Systems
        Tech Transfer / Scale-up
- Authorization / Approval
  - - - Go to Authorization / Approval section >>
  - - - Strategy and Consulting
        Market Access
      - Regulatory Affairs
        CMC Services
        Global Procedure Management
        Health Authority / Agency Interaction
        Marketing and Labeling Activities
        Regulatory Operations
        Scientific, Regulatory and Technical Writing
        Statistical Services
    - - Pharmacovigilance
        EU QPPV / National QPPV
        Pharmacovigilance Consulting
      - Quality
        Commercialization Readiness
        Commissioning, Qualification, and Validation (CQV)
        GxP Services
        Interim / Contract QA
        PAI Readiness
- Post-approval / Maintenance
  - - - Go to Post-approval / Maintenance section >>
  - - - Strategy and Consulting
        Market Access
      - Regulatory Affairs
        CMC Services
        Global End-to-End Outsourcing
        Global Procedure Management
        Health Authority / Agency Interaction
        Marketing and Labeling Activities
        Mergers and Acquisitions (M&A) Transfers
        Regulatory Operations
        Toxicology Services
      - Pharmacovigilance
        EU QPPV / National QPPV
        ICSR (Individual Safety Case Report) Management
        Literature Monitoring & Screening
        Pharmacovigilance Quality & Compliance
        Signal Management
    - - Quality
        Commissioning, Qualification, and Validation (CQV)
        GxP Services
        Interim / Contract QA
        Quality Management Systems
      - Medical Affairs
        Healthcare Compliance and Medical Approval
- Program Management
  - - - Go to Program Management section >>
      - Program Management
        Global End-to-End Outsourcing
        Global Procedure Management
        Integrated Product Development
        Mergers and Acquisitions (M&A) Transfers
- Featured Expertise
  - - - Industry Expertise
        Biopharmaceuticals
        MedTech Services
    - - Service Expertise
        ATMP / Cell and Gene Therapy
        COVID-19 Support
        GxP Services
        Market Access
        Pharmacovigilance Consulting
        Statistical Services
      - SMARTPHLEX - technology-enabled services
Global ReachGlobal Reach
Contact usContact us
News & Events
Resource Library
Careers
- Life at PharmaLex
- Career Opportunities
Training

Home > News & Events > Industry News Articles > Page 7

Category Archives: Industry News Articles

2019: Trending topics in Pharma

18th December 2019

PharmaLex joins forces with Vintura

13th December 2019

Serialisation – New EU Aide Memoire for GDP

11th December 2019

PharmaLex to plant 250 trees to celebrate its 25th anniversary

9th December 2019

Our 25th Biosimilar Molecule in Our 25th Year!

3rd December 2019

The shift in responsibility for IR35 compliance in the UK

27th November 2019

EMA guidance on biosimilars in the EU

25th November 2019

New EU Medical Device and In-Vitro Diagnostic Regulations

25th November 2019

PharmaLex Internal Audit Programme Management Services

14th November 2019

Technical Helpdesk Service

7th November 2019

2 3 4

…5 6 7 8 9 …

10 11 12 13 14 15 16 17 18

prev next

Upcoming Webinars

September 21st, 2021

Bayesian Methods for Joint Longitudinal and Survival Data

4:00 PM CET

October 12th, 2021

Gene therapy products: regulatory expectations and challenges for the industry

3:00 PM CET

Upcoming Events

September 22 - 24th, 2021

TOPRA Symposium 2021

Archive

USEFUL LINKS

Home
Contact us
Imprint
Data Protection
Terms and Conditions
Statistics and Data Science
MedTech Services

RECENT TWEETS

PharmaLex @PharmaLexGLOBAL·

15 Sep

Our experts will share their knowledge and discuss key #statistical and #regulatory issues in the joint modeling of longitudinal and survival data and offer guidance on Bayes-CMC methods.

Register for this free learning session: https://go.pharmalex.com/l/484291/2021-09-15/2ng8d4

#BayesianMethods

COVID-19 NEWSLETTER SIGN UP

WHAT OUR CLIENTS SAY

During the bid defense we felt that you worked well as team and are very dynamic. Preparation of such a complex dossier really needs to be done in such a way.

Large Pharma, Germany
VP Regulatory Affairs

ISO9001:2015 Logo

Please DO NOT send us event/conference information.
We will not respond and these will be deleted immediately.

Select your state:

Please tick this box to agree to our Privacy Policy

Please tick this box if you agree to periodic updates from PharmaLex.
You can unsubscribe at any time at data.protection@pharmalex.com

Please leave this field empty.

Click here to view our Privacy Policy.

#AskTheExpert #TogetherBEYONDCOVID19

Select your state:

Please tick this box to agree to our Privacy Policy

Please tick this box if you agree to periodic updates from PharmaLex.
You can unsubscribe at any time at data.protection@pharmalex.com

Please leave this field empty.

If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

#TogetherBEYONDCOVID19

We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for

Strategy and Consulting

Strategy and Consulting

Regulatory Affairs

Pharmacovigilance

Quality

Strategy and Consulting

Regulatory Affairs

Pharmacovigilance

Quality

Strategy and Consulting

Regulatory Affairs

Pharmacovigilance

Quality

Medical Affairs

Program Management

Industry Expertise

Service Expertise

PharmaLex joins forces with Vintura

Serialisation – New EU Aide Memoire for GDP

PharmaLex to plant 250 trees to celebrate its 25th anniversary

DIA Europe 2020

DIA RSIDM 2020

Our 25th Biosimilar Molecule in Our 25th Year!

The shift in responsibility for IR35 compliance in the UK

EMA guidance on biosimilars in the EU

New EU Medical Device and In-Vitro Diagnostic Regulations

PharmaLex Internal Audit Programme Management Services

Technical Helpdesk Service